RSS

Pierre Fabre

Merck, Array BioPharma and Pierre Fabre have initiated a prospective, randomised, global phase three clinical trial for a treatment of BRAF-mutant metastatic colorectal cancer (mCRC) more

News

Pierre Fabre Laboratories is launching Nature Open Library, an Open Innovation programme more

News

Array BioPharma and Pierre Fabre have announced a collaboration to globally develop and commercialise Array's late-stage novel oncology products, binimetinib and encorafenib more

News